Redefining Weight Loss Goals: Tirzepatide vs Semaglutide – Mounjaro: A New Era in Diabetes & Weight Management

Date: 21 August, 2025

Dr. Sudhir Bhandari contributed to the academic programme at Mounjaro: A New Era in Diabetes & Weight Management with a session focused on Redefining Weight Loss Goals: Tirzepatide vs Semaglutide.

Programme: Mounjaro: A New Era in Diabetes & Weight Management
Academic Focus: Redefining Weight Loss Goals: Tirzepatide vs Semaglutide